Clinical Trials Browser

Phase 1 × Unknown × talimogene laherparepvec × Clear all

NCT03747744 2020-12-29

myDCTV

Phase 1 Unknown

Melanoma

NCT03088176 2020-10-12

Combining Talimogene Laherparepvec With BRAF and MEK Inhibitors in BRAF Mutated Advanced Melanoma

Phase 1 Unknown

Melanoma